Related Experiment Video
Updated: Nov 23, 2025
Normothermic Ex Vivo Kidney Perfusion for the Preservation of Kidney Grafts prior to Transplantation
Published on: July 15, 2015
Hypothermic machine perfusion utilization and outcomes for deceased-donor kidneys: A retrospective cohort study
Vijay Krishnamoorthy1,2, Qian Qiu3, Michael J Souter4
1Department of Anesthesiology, Duke University, Durham, NC, USA.
Introduction:
Hypothermic machine perfusion (HMP) has been established as an efficacious method for preserving kidney allografts from deceased donors in clinical trials, but little data are available on the effectiveness of HMP in real-world settings. We examined factors associated with HMP use and clinical outcomes in a real-world organ procurement organization setting.
Methods:
We conducted a retrospective cohort study of the Lifecenter Northwest organ procurement database from 2010 to 2015, linked to the United Network of Organ Sharing outcomes database. We examined HMP utilization, and our primary outcomes were delayed graft function (DGF) and graft survival, using multivariable Poisson and Cox regression models.
Results:
Among 1729 deceased-donor kidneys, 797 (46%) were preserved with HMP. Higher donor age, region of procurement, and donation type were associated with HMP use. HMP was associated with a 37% decreased risk of DGF (adjusted relative risk 0.63, 95% confidence interval [CI]: 0.51-0.78), with no effect on 1-year graft survival (adjusted hazard ratio 0.83, 95% CI: 0.38-1.80).
Conclusion:
Variation exists in the utilization of HMP for deceased donor kidneys. HMP reduced the risk for DGF, but was not associated with improvements in long-term graft survival.
